Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -88.59%-13.23M | -43.35%-9.95M | -1,141.32%-7.56M | 16.36%-23.13M | -217.35%-8.56M | -48.56%-7.02M | 38.60%-6.94M | 93.18%-608.98K | -7.52%-27.65M | 62.07%-2.7M |
| Net income from continuing operations | -138.52%-16.56M | -172.69%-12.88M | -519.89%-9.02M | -33.54%-25.1M | -388.04%-11.98M | -124.01%-6.94M | 32.79%-4.72M | 76.57%-1.46M | 10.10%-18.79M | 54.32%-2.45M |
| Operating gains losses | 149.82%794.94K | 116.20%137.14K | -14.96%-643.55K | 73.98%-2.95M | 104.28%51.06K | 9.72%-1.6M | 83.36%-846.32K | 82.99%-559.82K | -5.16%-11.34M | 54.63%-1.19M |
| Depreciation and amortization | 401.08%19.89K | --18.61K | --17.85K | 83.83%20.89K | 52,790.63%16.93K | 41.15%3.97K | --0 | --0 | 65.59%11.37K | 100.49%32 |
| Remuneration paid in stock | 318.07%2.57M | 114.06%978.4K | 582.15%1.36M | 61.64%2.75M | 396.93%1.48M | 40.70%615.38K | -17.85%457.06K | -51.40%199.5K | -13.34%1.7M | -21.21%297.59K |
| Other non cashItems | -161.13%-179.85K | -65.43%97.45K | 21.04%324.79K | 17.05%1.16M | 18.08%312.37K | 17.00%294.2K | 17.13%281.85K | 15.84%268.32K | -73.32%988.25K | 19.10%264.53K |
| Change In working capital | -80.86%116.13K | 180.68%1.7M | -57.02%403.44K | 548.27%990.99K | 300.74%1.55M | 210.55%606.65K | -21,125.32%-2.11M | 1,436.17%938.57K | -175.39%-221.07K | 30.62%387.89K |
| -Change in receivables | -108.33%-70.66K | 213.20%114.16K | 98.20%-12.35K | 209.87%161.27K | 416.41%98.27K | 2,150.42%848.11K | -54.11%-100.85K | -7,571.96%-684.26K | -16.00%-146.78K | 82.15%-31.06K |
| -Change in prepaid assets | -8,447.68%-2.29M | 215.65%2.17M | -99.34%10.64K | -148.31%-22.99K | 4,431.71%278.84K | -281.61%-26.78K | -1,432.30%-1.88M | 1,502.70%1.6M | -33.46%47.59K | 134.52%6.15K |
| -Change in payables and accrued expense | 1,253.32%2.48M | -357.11%-586.6K | 2,099.26%405.15K | 799.65%852.72K | 185.21%1.18M | 58.88%-214.69K | -95.63%-128.33K | -65.28%18.42K | -135.00%-121.88K | -15.54%412.79K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -88.37%-13.25M | -43.35%-9.95M | -1,141.32%-7.56M | 16.36%-23.13M | -216.69%-8.54M | -48.94%-7.03M | 38.60%-6.94M | 93.18%-608.98K | -7.52%-27.65M | 62.07%-2.7M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -169.50%-960.6K | -1,760.26%-14.11M | -130.46%-1.05M | -25.23%6.77M | -6.95%1.1M | -41.74%1.38M | -69.33%849.84K | 25.94%3.44M | 18.63%9.06M | 79.22%1.18M |
| Net PPE purchase and sale | -38.13%-1.16M | ---55.86K | -140.03%-1.67M | -52.56%-3.12M | ---1.59M | 43.71%-840.81K | --0 | -25.55%-695.1K | -291.48%-2.05M | --0 |
| Net investment purchase and sale | -94.50%200.84K | -1,753.69%-14.05M | -77.09%620.24K | -10.89%9.89M | 127.65%2.68M | -5.54%3.65M | -69.33%849.84K | -17.62%2.71M | 36.12%11.1M | 58.02%1.18M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --1.43M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -169.50%-960.6K | -1,760.26%-14.11M | -130.46%-1.05M | -25.23%6.77M | -6.95%1.1M | -41.74%1.38M | -69.33%849.84K | 25.94%3.44M | 18.63%9.06M | 79.22%1.18M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,346.00%275.18K | -147.95%-9.56M | 37,367.49%56.39M | 256.15%27.76M | 10,846.68%7.67M | -75.95%11.25K | 193.80%19.93M | -85.45%150.5K | -40.50%7.8M | -100.76%-71.33K |
| Net issuance payments of debt | --0 | ---9.66M | --0 | --0 | --0 | --0 | --0 | --0 | 31.48%-12.92K | --0 |
| Net common stock issuance | --0 | --0 | --56.22M | --19.96M | --926.61K | --0 | --19.03M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 2,346.00%275.18K | -88.73%101.75K | 12.29%169K | -1.11%7.8M | 56,058.26%6.74M | -77.50%11.25K | -86.71%902.62K | -85.52%150.5K | 100.42%7.89M | -94.68%12K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 30.84%-83.33K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,346.00%275.18K | -147.95%-9.56M | 37,367.49%56.39M | 256.15%27.76M | 10,846.68%7.67M | -75.95%11.25K | 193.80%19.93M | -85.45%150.5K | -40.50%7.8M | -100.76%-71.33K |
| Net cash flow | ||||||||||
| Beginning cash position | 41.46%27.85M | 979.84%61.49M | 390.69%13.73M | -79.76%2.8M | 203.41%13.98M | 185.23%19.68M | -34.32%5.69M | -79.76%2.8M | -27.31%13.82M | -57.12%4.61M |
| Current changes in cash | -147.05%-13.94M | -342.80%-33.62M | 1,502.03%47.78M | 205.59%11.4M | 113.75%218.66K | -144.86%-5.64M | 893.09%13.85M | 157.78%2.98M | -116.71%-10.8M | -153.93%-1.59M |
| Effect of exchange rate changes | -1,631.03%-1.03M | -118.34%-26.64K | 78.90%-18.06K | -111.82%-475.84K | -114.83%-476.03K | -616.28%-59.45K | 754.35%145.23K | -1,223.96%-85.6K | -7.70%-224.65K | -276.70%-221.58K |
| End cash Position | -7.89%12.88M | 41.46%27.85M | 979.84%61.49M | 390.69%13.73M | 390.69%13.73M | 203.41%13.98M | 185.23%19.68M | -34.32%5.69M | -79.76%2.8M | -79.76%2.8M |
| Free cash from | -83.00%-14.41M | -44.15%-10M | -607.61%-9.23M | 11.61%-26.25M | -275.53%-10.13M | -26.68%-7.88M | 38.60%-6.94M | 86.25%-1.3M | -13.18%-29.7M | 62.54%-2.7M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.